i n f l a r x

Loading

Press Release

Home Investors Press Releases Press Release

InflaRx’s Marketing Authorization Application (MAA) for Vilobelimab for Treatment of Critically Ill COVID-19 Patients under Review by European Medicines Agency (EMA)

Aug 30, 2023

Time to read 4 Minutes

Download PDF

Back